
Epixone-SL 250mg/125mg Injection
Marketer
Epitome Life Sciences
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Epixone-SL 250mg/125mg Injection
Combiflox-250 Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be strictly under medical guidance; complete the prescribed regimen, even with symptom improvement, to maximize efficacy. Premature cessation may compromise treatment. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects immediately. Seek immediate medical attention for allergic reactions (rash, pruritus, edema, dyspnea). Inform your physician of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration contribute to faster recovery. Laboratory monitoring may be employed to assess treatment response.
Primary Ingredients of Epixone-SL 250mg/125mg Injection
There is no text provided to rephrase.
Uses of Epixone-SL 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Epixone-SL 250mg/125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Epixone-SL 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Epixone-SL 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not advised.
How Epixone-SL 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Epixone-SL 250mg/125mg Injection, offer a powerful antibacterial approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Sulbactam, a beta-lactamase inhibitor, complements Ceftriaxone by countering bacterial resistance mechanisms, thus improving the antibiotic's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Epixone-SL 250mg/125mg Injection use alongside alcohol consumption presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Sublingual Epixone (250mg/125mg) injection is typically regarded as safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Epixone-SL 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Epixone-SL 250mg/125mg Injection could reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving is prohibited should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data on Epixone-SL 250mg/125mg Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Individuals with severe hepatic impairment should use Epixone-SL 250mg/125mg Injection cautiously, potentially requiring dosage modification. Medical advice is recommended. Dosage alteration for Epixone-SL 250mg/125mg Injection is unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Epixone-SL 250mg/125mg Injection :
Omitting a scheduled dose of Epixone-SL 250mg/125mg Injection warrants immediate physician consultation.
Facts to Know About Epixone-SL 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
